FINANCIAL STATEMENTS ASTRAZENECA ANNUAL REPORT AND FORM 20-F INFORMATION 2007 175 NOTES TO THE FINANCIAL STATEMENTS CONTINUED 29 STATUTORY AND OTHER INFORMATION 2007 2006 2005 $m $m $m Fees payable to KPMG Audit Plc and its associates: Group audit fee 3.6 3.1 2.5 Fees payable to KPMG Audit Plc and its associates for other services: The audit of subsidiaries pursuant to legislation 6.1 5.4 5.0 Other services pursuant to legislation 3.6 4.1 0.8 Taxation 1.1 1.2 1.0 All other services 0.7 1.0 2.2 Fees payable to KPMG Audit Plc in respect of the Groups pension schemes: The audit of subsidiaries pension schemes 0.6 0.5 0.5 15.7 15.3 12.0 Other services pursuant to legislation includes fees of $2.7m 2006 $3.2m, 2005 $nil in respect of section 404 of the Sarbanes-Oxley Act.
All other services includes $nil 2006 $nil, 2005 $1.8m in respect of section 404 of the Sarbanes-Oxley Act.
Included within the Group audit fee is an amount of $0.1m 2006 $0.1m in respect of the audit of the Company.
Taxation services consist of tax compliance services and tax advice.
Related party transactions The Group had no material related party transactions which might reasonably be expected to influence decisions made by the users of these Financial Statements.
Key management personnel compensation 2007 2006 2005 $000 $000 $000 Short-term employee benefits 31,525 21,321 19,334 Post-employment benefits 2,072 3,191 1,731 Share-based payments 11,515 8,417 5,663 45,112 32,929 26,728 Short-term employee benefits in 2007 include one-off employee costs of $11m in relation to the acquisition of MedImmune.
Total remuneration is included within employee costs Note 26.
Subsequent events There were no material subsequent events.
